LitAlert ~~ GeneLit.com

    • Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History.
    • Jeroen J van den Broek, PhD, Clyde B Schechter, MD, MA, Nicolien T van Ravesteyn, PhD, A Cecile J W Janssens, PhD, Michael C Wolfson, PhD, Amy Trentham-Dietz, PhD, Jacques Simard, PhD, Douglas F Easton, PhD, Jeanne S Mandelblatt, MD, MPH, Peter Kraft, PhD, Harry J de Koning, MD, PhD.
    • J Natl Cancer Inst. 2020 Aug 27. pii: djaa127. doi: 10.1093/jnci/djaa127. [Epub ahead of print]

    • Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer.
    • Burcu F Darst, PhD, Tokhir Dadaev, MSc, Ed Saunders, MRes, Xin Sheng, MS, Peggy Wan, MA, Loreall Pooler, BS, Lucy Y Xia, MS, Stephen Chanock, MD, Sonja I Berndt, PharmD, PhD, Susan M Gapstur, PhD, Victoria Stevens, PhD, Demetrius Albanes, MD, Stephanie J Weinstein, PhD, Vincent Gnanapragasam, BMedSci, MBBS, MA, PhD, FRCS, FRCSEe(Urol), Graham G Giles, PhD, Tu Nguyen-Dumont, PhD, Roger L Milne, PhD, Mark Pomerantz, MD, Julie A Schmidt, DPhil, Lorelei Mucci, MPH, ScD, William J Catalona, MD, Kurt N Hetrick, MS, Kimberly F Doheny, PhD, Robert J MacInnis, PhD, Melissa C Southey, PhD, Rosalind A Eeles, PhD, Fredrik Wiklund, PhD, Zsofia Kote-Jarai, PhD, David V Conti, PhD, Christopher A Haiman, ScD
    • J Natl Cancer Inst. 2020 Aug 27. pii: djaa032. doi: 10.1093/jnci/djaa132. [Epub ahead of print]

    • Informing models of cancer genetic care in the era of multigene panel testing with patient-led recommendations.
    • Underhill-Blazey M, Blonquist T, Chittenden A, Pozzar R, Nayak M, Lansang K, Hong F, Garber J, Stopfer JE.
    • J Genet Couns. 2020 Aug 26. doi: 10.1002/jgc4.1317. Epub ahead of print.

    • Next generation sequencing analysis of BRCA1 and BRCA2 identifies novel variations in breast cancer.
    • Tacar SY, Bozgeyik E, Seber ES, Yetisyigit T, Tozkir H, Avci O, Arslan A.
    • Life Sci. 2020 Aug 23:118334. doi: 10.1016/j.lfs.2020.118334. Epub ahead of print.

    • Metastatic Castration-Resistant Prostate Cancer with Neuroendocrine Transformation and BRCA 1 Germ-Line Mutation: A Case Report and Literature Review.
    • Wu Y, Gao Y, Dou X, Yue J.
    • Onco Targets Ther. 2020 Aug 12;13:8049-8054. doi: 10.2147/OTT.S264347.

    • Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) for prophylactic bilateral salpingo-oophorectomy.
    • Goldenberg M, Burke YZ, Matanes E, Lowenstein L.
    • Surg Oncol. 2020 Aug 6;35:79-80. doi: 10.1016/j.suronc.2020.07.006. Epub ahead of print.
    • Case report

    • PARP Inhibitors in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials.
    • Wang Y, Ren F, Song Z, Wang X, Zhang C, Ouyang L.
    • Front Oncol. 2020 Aug 4;10:1204. doi: 10.3389/fonc.2020.01204.

    • Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects.
    • Peixoto A, Pinto P, Guerra J, Pinheiro M, Santos C, Pinto C, Santos R, Escudeiro C, Bartosch C, Canário R, Barbosa A, Gouveia A, Petiz A, Abreu MH, Sousa S, Pereira D, Silva J, Teixeira MR.
    • Front Oncol. 2020 Jul 31;10:1318. doi: 10.3389/fonc.2020.01318.